Dr Craig Jamieson


Pure and Applied Chemistry


Design, synthesis and evaluation of E2-25K derived stapled peptides
Watson Morag E, Scott Daniel, Jamieson Craig, Layfield Robert, Mason Andrew M
Peptide Science (2020)
Photocatalytic E→Z Isomerization of β-Ionyl Derivatives
Livingstone Keith, Tenberge Marius, Pape Felix, Daniliuc Constantin G, Jamieson Craig, Gilmour Ryan
Organic Letters Vol 21, pp. 9677-9680 (2019)
Metal free C-C bond formation via coupling of nitrile imines and boronic acids
Livingstone Keith, Betrand Sophie, Mowat Jenna, Jamieson Craig
Chemical Science Vol 10, pp. 10412-10416 (2019)
A fragment-like approach to PYCR1 inhibition
Milne Kirsty, Sun Jianhui, Zaal Esther A, Mowat Jenna, Celie Patrick HN, Fish Alexander, Berkers Celia R, Forlani Giuseppe, Loayza-Puch Fabricio, Jamieson Craig, Agami Reuven
Bioorganic and Medicinal Chemistry Letters Vol 29, pp. 2626-2631 (2019)
A reappraisal of the Ni-[(Benzylprolyl)amino]benzophenone complex in the synthesis of α,α-disubstituted amino acid derivatives
Watson Morag E, Jamieson Craig, Kennedy Alan R, Mason Andrew M
Tetrahedron Vol 75 (2019)
Atom efficient synthesis of selectively difluorinated carbocycles through a gold(I) catalyzed cyclization
McCarter Adam W, Sommer Magdalana, Percy Jonathan M, Jamieson Craig, Kennedy Alan R, Hirst David J
Journal of Organic Chemistry (2018)

more publications

Research interests


Craig Jamieson earned his BSc (Hons) in Chemistry at the University of Glasgow in 1996. His PhD studies were carried out under the direction of Professor R Ramage at the University of Edinburgh (1999).  Following postdoctoral research under the supervision of Professor S V Ley at the University of Cambridge, in 2001 he was appointed as a Principal Scientist in GlaxoSmithKline's Discovery Medicinal Chemistry group working on a range of exploratory medicinal chemistry programmes.  In 2004, Dr Jamieson joined Organon Laboratories (later Merck Research Labs) as a Group Leader in the Medicinal Chemistry Department, with responsibility for hit to clincal candidate optimisation.  In August 2010 he was appointed as a John Anderson Research Lecturer in Chemical Biology, based in the Department of Pure and Applied Chemistry at the University of Strathclyde.

Research Interests

A major area of focus for our research continues to be in the Chemistry-Biology-Medicine continuum.  In this regard, we have a number of active programmes centred around hit and lead identification on disease targets and mechanisms in areas of significant societal need, particularly in diseases of ageing.  Allied to our work in the medicinal chemistry sphere, we also have a keen interest in the development of novel, enabling synthetic methodologies to enhance the armamentarium of molecule makers working in our arena.  We collaborate with groups and industrial partners locally, nationally and globally in order to effectively meet our research goals.

Professional activities

Gyros Protein Technologies
Visiting researcher
Almac Sciences
Visiting researcher
Aldeyra Therapeutics Inc
Arc Scientific
Syngenta Limited
Visiting researcher
Journal of the American Chemical Society (Journal)
Peer reviewer

more professional activities


Development and preclinical validation of novel PAR2 inhibitors for the treatment of Osteoarthritis
McIntosh, Kathryn (Principal Investigator) Crilly, Anne (Co-investigator) Jamieson, Craig (Co-investigator) Plevin, Robin (Co-investigator) Rattray, Zahra (Co-investigator)
01-Jan-2020 - 30-Jan-2021
The Androgen Receptor-amino terminal domain a Novel Druggable Target in the Treatment of Castrate
Jamieson, Craig (Principal Investigator)
01-Jan-2019 - 31-Jan-2022
Industrial CASE Account - University of Strathclyde 2017 | Mowat, Jenna
Jamieson, Craig (Principal Investigator) Burley, Glenn (Co-investigator) Mowat, Jenna (Research Co-investigator)
01-Jan-2019 - 01-Jan-2023
Doctoral Training Partnership 2018-19 University of Strathclyde | Mowat, Jenna
Jamieson, Craig (Principal Investigator) Burley, Glenn (Co-investigator) Mowat, Jenna (Research Co-investigator)
01-Jan-2019 - 01-Jan-2023
Accelerated Discovery and Development of New Medicines: Prosperity Partnership for a Healthier Nation
Kerr, William (Principal Investigator) Florence, Alastair (Co-investigator) Jamieson, Craig (Co-investigator) Johnston, Blair (Co-investigator) Murphy, John (Co-investigator) Palmer, David (Co-investigator) Tomkinson, Nick (Co-investigator)
01-Jan-2019 - 31-Jan-2023
Industrial CASE Account - University of Strathclyde 2018 | Bunschoten, Roderick
Burley, Glenn (Principal Investigator) Jamieson, Craig (Co-investigator) Bunschoten, Roderick (Research Co-investigator)
01-Jan-2018 - 01-Jan-2022

more projects


Pure and Applied Chemistry
Thomas Graham Building

Location Map

View University of Strathclyde in a larger map